编者按： 肿瘤筛查，是液态活检将来非常有吸引力和竞争力的一个发展方向。笔者认为，液态活检并不能孤立地，或一枝独秀地解决肿瘤筛查、诊断的问题，即使是对特定的某一种肿瘤。充分地与现有肿瘤筛查指南结合，取长补短，协同作用，发挥"1+1>2"的效应，才是有希望的发展方向。因此，我特地整理了较权威的各类肿瘤筛查指南，为日后结合液态活检技术，建立一个更加完美的肿瘤筛查体系提供一个基本框架。 注：指南括号后显示的是最新版本标记。指南全文可从指南发布机构网站获取，或“医脉通”网站。指南主要来源于美国和欧洲相关机构。国内采用指南为收集。 乳腺癌筛查指南
Breast Cancer Screening Guidelines (2003) Guidelines for Breast Screening with MRI as an Adjunct to Mammography (2007)
Breast Cancer Risk Reduction （2015. v2） Breast Cancer Screening and Diagnosis （2015. v1） Genetic/Familial High-Risk Assessment: Breast and Ovarian （2015. v2）
European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis (4th Edition)
Suspected cancer：recognition and referral （NG12） 子宫颈癌
Cervical Cancer Screening
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors （2012）
European Guidelines for Quality Assurance in Cervical Cancer Screening (2nd Edition)
Suspected cancer：recognition and referral （NG12） 肠癌
Colorectal Cancer Screening （2015. v1） Genetic/Familial High-Risk Assessment: Colorectal （2015. v1）
Screening for Colorectal Cancer: USPSTF Recommendation Statement (October 2008)
European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis (1st Edition)
Suspected cancer：recognition and referral （NG12） 前列腺癌
Prostate Cancer Early Detection (2015. v2）
Early Detection of prostate cancer: AUA Guideline (2013)
EAU guidelines on prostate cancer (2015)
Suspected cancer：recognition and referral （NG12） |
/3 
浙公网安备33010802005999号 
